Effects of Weipixiao (胃痞消) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions.
- Author:
Jin-hao ZENG
1
;
Hua-feng PAN
2
;
You-zhang LIU
1
;
Hai-bo XU
3
;
Zi-ming ZHAO
4
;
Hai-wen LI
1
;
Jin-ling REN
1
;
Long-hui CHEN
1
;
Xia HU
1
;
Yan YAN
1
Author Information
- Publication Type:Journal Article
- Keywords: Chinese medicine; Lgr5; Weipixiao; Wnt/ß-catenin pathway; Wnt1; Wnt3a; gastric precancerous lesions; matrix metalloproteinase-7; ß-catenin
- MeSH: Animals; Drugs, Chinese Herbal; pharmacology; therapeutic use; Epithelial Cells; drug effects; metabolism; pathology; Gastric Mucosa; pathology; Immunohistochemistry; Male; Matrix Metalloproteinase 7; metabolism; Precancerous Conditions; drug therapy; pathology; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; metabolism; Staining and Labeling; Stomach Neoplasms; drug therapy; pathology; Wnt Proteins; metabolism; Wnt Signaling Pathway; drug effects; beta Catenin; metabolism
- From: Chinese journal of integrative medicine 2016;22(4):267-275
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the effects of Weipixiao (胃痞消, WPX) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions (GPL).
METHODSSprague Dawley rats were randomly divided into control, model, vitacoenzyme (0.2 g·kg(-1)·day(-1)), WPX high-dose (H-WPX, 15 g·kg(-1)·day(-1)), WPX medium-dose (M-WPX, 7.5 g·kg(-1)·day(-1)) and WPX low-dose (L-WPX, 3.75 g·kg(-1)·day(-1)) groups. After successfully establishing the GPL model, the rats were consecutively administered WPX or vitacoenzyme by gastrogavage for 10 weeks. Differential expression of Leucine-rich repeat-containing G-proteincoupled receptor 5 (Lgr5), matrix metalloproteinase-7 (MMP-7), Wnt1, Wnt3a, and β-catenin in gastric mucosal epithelial cells in all groups were immunohistochemically detected, and the images were taken and analyzed semiquantitatively by image pro plus 6.0 software.
RESULTSGastric epithelium in the model group showed significantly higher expression levels of Lgr5, MMP-7, Wnt1, Wnt3a and β-catenin than those of the control group(P<0.01). Interestingly, we also observed Lgr5+ cells, which generally located at the base of the gastric glandular unit, migrated to the luminal side of gastric epithelium with GPL. The expression levels of Lgr5, MMP-7, Wnt1, and β-catenin were all down-regulated in the L-WPX group as compared with those of both model and vitacoenzyme groups (P<0.05). A similar, but nonsignificant down-regulation in expression level of Wnt3a was noted in all WPX groups (P>0.05).
CONCLUSIONOur findings suggested that the therapeutic mechanisms of WPX in treating GPL might be related with its inhibitory effects on the expressions of Lgr5, MMP-7, Wnt1, β-catenin and the aberrant activation of Wnt/β-catenin pathway.